Data as of Aug 22
| +0.07 / +0.19%|
The 8 analysts offering 12-month price forecasts for WuXi Pharmatech (Cayman) Inc have a median target of 41.00, with a high estimate of 45.00 and a low estimate of 37.00. The median estimate represents a +10.93% increase from the last price of 36.96.
The current consensus among 10 polled investment analysts is to Buy stock in WuXi Pharmatech (Cayman) Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.